1161775-44-5

Upstream product

• 1515-87-3 methyl 3-(methoxymethyl)benzoate 
• 39687-95-1 isocyanoacetic acid methyl ester 
• 199742-77-3 3-(methoxymethyl)benzoyl chloride 
• 1129-28-8 3-methoxycarbonylbenzyl bromide 
• 32194-76-6 3-methoxymethyl-benzoic acid 
• 1161775-42-3 5-(3-hydroxymethyl-phenyl)-oxazole-4-carboxylic acid 
• 74-88-4 methyl iodide 

Downstream Products

• 1161775-46-7 5-(3-methoxymethyl-phenyl)-oxazole-4-carboxylic acid 
• 1373766-48-3 4-(bromomethyl)-5-(3-(methoxymethyl)phenyl)oxazole 
• 1373766-47-2 (5-(3-(methoxymethyl)phenyl)oxazole-4-yl)methanol 
• 1373766-52-9 (5-(3-(methoxymethyl)phenyl)-2-methyloxazole-4-yl)methanol 
• 1373766-49-4 methyl 2-amino-3-(3-(methoxymethyl)phenyl)-3-oxopropanoate 
• 1373766-51-8 methyl 2-methyl-5-(3-(methoxymethyl)phenyl)oxazole-4-carboxylate 
• 1373766-50-7 methyl 2-acetamido-3-(3-(methoxymethyl)phenyl)-3-oxopropanoate 
• 1373766-53-0 4-(bromomethyl)-5-(3-(methoxymethyl)phenyl)-2-methyloxazole 

Relevant academic research and scientific papers

DIAZA-SPIRO[5.5]UNDECANES USEFUL AS OREXIN RECEPTOR ANTAGONISTS

The invention relates to compound of the formula (I), in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.

Diaza-spiro[5.5]undecanes

The invention relates to compound of the formula I in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.

Di/tri-aza-spiro-C9-C11alkanes

The invention relates to compounds of the formula I [in-line-formulae]A-D-C(R1)2—B??(I),[/in-line-formulae] in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.

DI/TRI-AZA-SPIRO-C9-C11ALKANES

The invention relates to compounds of the formula I A-D-C(R1)2-B (I), in which A and B are aromatic ring systems and wherein D is selected from the groups D1 to D5 and the other substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.

AMINOTRIAZOLE DERIVATIVES AS ALX AGONISTS

The invention relates to aminotriazole derivatives of formula (I), wherein A, E, R1 and R2 are as defined in the description, their preparation and their use as pharmaceutically active compounds. The compounds are useful for the prevention or treatment of diseases, which respond to the modulation of the ALX receptor such as inflammatory diseases.